Chen Hu

R. Ivkov, F. Lin, Chen Hu, 2020, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521).

R. Hannan, J. Purdy, M. Amin, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer in NRG Oncology/RTOG 0617

J. Galvin, P. Iyengar, H. Choy, 2015 .

Quality of Life (QOL) Analysis of the Randomized Radiation (RT) Dose-Escalation NSCLC Trial (RTOG 0617): The Rest of the Story

H. Choy, J. Sloan, J. Bradley, 2013 .

High-dose hypofractionated stereotactic body radiotherapy for spinal chordoma.

C. Bettegowda, D. Sciubba, Chen Hu, 2021, Journal of neurosurgery. Spine.

Radiation Therapy Oncology Group (RTOG) Protocol 0915: A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer

Anurag K. Singh, H. Choy, G. Videtic, 2013 .

Association of Pathologic Complete Response and Long-Term Survival Outcomes Among Patients Treated With Neoadjuvant Chemotherapy or Chemoradiotherapy for NSCLC: A Meta-Analysis

Chen Hu, P. Forde, S. Rosner, 2022, JTO clinical and research reports.

Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer.

J. Curtis, S. Jolly, R. T. Ten Haken, 2020, International journal of radiation oncology, biology, physics.

Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR‐TKI treatment in advanced non‐small cell lung cancer

Di Wu, Chen Hu, Yong He, 2022, Thoracic cancer.

Evaluation of a novel absorbable radiopaque hydrogel in patients undergoing image-guided radiotherapy (IGRT) for borderline resectable and locally advanced pancreatic adenocarcinoma.

K. Ding, E. Fishman, elliot k fishman, 2019, Practical radiation oncology.

Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non–Small Cell Lung Cancer

J. Galvin, H. Choy, R. Timmerman, 2018, JAMA oncology.

Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505).

W. Curran, R. Jeraj, J. Bradley, 2017, Clinical lung cancer.

Molecular Characterization and Clinical Relevance of N6-Methyladenosine Regulators in Metastatic Prostate Cancer

F. Zhou, Zhuguo Li, Chen Hu, 2022, Frontiers in Oncology.

Initial reporting of NRG-LU001 (NCT02186847), randomized phase II trial of concurrent chemoradiotherapy (CRT) +/- metformin in locally advanced Non-Small Cell Lung Cancer (NSCLC).

J. Bradley, J. Erasmus, Richard J Lee, 2019, Journal of Clinical Oncology.

Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.

R. Hannan, H. Sandler, J. Purdy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

J. Galvin, P. Iyengar, H. Choy, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.

W. Curran, H. Choy, J. Sloan, 2016, JAMA oncology.

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive‐Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937

R. Hales, P. Iyengar, J. Bradley, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Utility of a Clinical Decision Support System in Weight Loss Prediction After Head and Neck Cancer Radiotherapy.

Junghoon Lee, J. Wong, S. Greco, 2019, JCO Clinical Cancer Informatics.

Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significance.

Chen Hu, Yi Liu, Liang Liu, 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

K. Forster, P. Iyengar, H. Choy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.

H. Choy, M. Suntharalingam, L. Gaspar, 2019, JAMA oncology.

Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131

D. Brachman, M. Mehta, M. Vogelbaum, 2015, Journal of Neuro-Oncology.

Impact of biochemical failure classification on clinical outcome: A secondary analysis of Radiation Therapy Oncology Group 9202 and 9413

H. Sandler, K. Bae, W. Shipley, 2015, Cancer.

Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.

E. Shaw, D. Brachman, J. Buckner, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of Duration of Response vs Conventional Response Rates and Progression-Free Survival as Efficacy End Points in Simulated Immuno-oncology Clinical Trials

Meihua Wang, Chen Hu, Cong Chen, 2021, JAMA network open.

Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung Cancer

Jinming Yu, Chen Hu, F. Kong, 2019, JAMA network open.

Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617

W. Curran, P. Iyengar, H. Choy, 2021, Cancers.

Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies

Junghoon Lee, C. Lin, R. Hales, 2021, The oncologist.

Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.

S. Coons, D. Brachman, M. Mehta, 2015, International journal of radiation oncology, biology, physics.

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

R. Tsang, Chen Hu, Gang Wu, 2020, Leukemia.

Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy

Jie He, Jun Liang, Chen Hu, 2021, JAMA oncology.

Quality of Life After Partial or Whole-Breast Irradiation in Breast-Conserving Therapy for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled Trial

Chen Hu, Shulian Wang, J. Jin, 2021, Frontiers in Oncology.

Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity

R. Hruban, elliot k fishman, Chen Hu, 2022, Annals of Surgical Oncology.

Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.

Chen Hu, Shulian Wang, J. Jin, 2019, The Lancet. Oncology.

Neoadjuvant Chemoradiation Compared With Neoadjuvant Radiation Alone in the Management of High-Grade Soft Tissue Extremity Sarcomas

C. Meyer, Chen Hu, S. Terezakis, 2019, Advances in radiation oncology.

Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial.

J. Bradley, J. Erasmus, R. Mcgarry, 2021, JAMA oncology.

Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer.

M. Suntharalingam, B. Loo, J. Bradley, 2020, The Journal of thoracic and cardiovascular surgery.

Propensity score adjusted analysis of patients with isolated locoregional recurrence versus de novo locally advanced NSCLC treated with definitive therapy.

R. Hales, Chen Hu, P. Han, 2020, Lung cancer.

Exploring the Relationship of Radiation Dose Exposed to the Length of Esophagus and Weight Loss in Patients with Lung Cancer.

R. Hales, T. McNutt, H. Quon, 2020, Practical radiation oncology.

Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer.

J. Hayman, A. Jackson, Jian-Yue Jin, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non–Small Cell Lung Cancer: NRG Oncology RTOG 0839

B. Loo, M. Diehn, J. Bradley, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Learning From Trials on Radiation Dose in Non-Small Cell Lung Cancer.

J. Bradley, Chen Hu, 2016, International journal of radiation oncology, biology, physics.

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.

Christopher U. Jones, J. Torres-Roca, H. Sandler, 2015, International journal of radiation oncology, biology, physics.

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

Christopher U. Jones, H. Sandler, A. Raben, 2017, Advances in radiation oncology.

Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group.

Chen Hu, Gang Wu, Yu-jing Zhang, 2018, Blood advances.

Predicting Recurrence Patterns Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma

Chen Hu, Jin He, G. D. Ivey, 2022, Annals of Surgical Oncology.

Higher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Non–small Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617)

W. Curran, P. Iyengar, H. Choy, 2017 .

Radiotherapy Fraction in Limited-Stage Small Cell Lung Cancer in the Modern Era: A Systematic Review and Meta-Analysis of 8006 Reconstructed Individual Patient Data

Chen Hu, N. Bi, Linfa Wu, 2022, Cancers.

Stage‐dependent conditional survival and failure hazard of non‐metastatic nasopharyngeal carcinoma after intensity‐modulated radiation therapy: Clinical implications for treatment strategies and surveillance

Chen Hu, J. Yi, Qingfeng Liu, 2021, Cancer medicine.

External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Predict Survival in Patients With Symptomatic Bone Metastases.

Thomas J. Smith, S. Zeger, T. DeWeese, 2021, JCO clinical cancer informatics.

Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients

S. Klein, R. Ursin, A. Pekosz, 2021, Open forum infectious diseases.

External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Improve Estimation of Life Expectancy

Thomas J. Smith, S. Zeger, T. DeWeese, 2020 .

Deviation from consensus contouring guidelines predicts inferior local control after spine stereotactic body radiotherapy.

D. Sciubba, Chen Hu, L. Kleinberg, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy

H. Francis, Chen Hu, D. Rigamonti, 2017, Front. Oncol..

788 Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety and cerebrospinal fluid biomarkers

A. Venkatesan, C. Bettegowda, E. Lipson, 2020 .

A Prospective Cohort Study of Neural Progenitor Cell-Sparing Radiation Therapy Plus Temozolomide for Newly Diagnosed Patients With Glioblastoma.

T. Vannorsdall, Chen Hu, A. Quiñones‐Hinojosa, 2020, Neurosurgery.

Impact of Incidental Cardiac Radiation on Cardiopulmonary Toxicity and Survival for Locally Advanced Non-Small Cell Lung Cancer: Reanalysis of NRG Oncology/RTOG 0617 With Centrally Contoured Cardiac Structures

P. Iyengar, J. Welsh, J. Bradley, 2016 .

Neoadjuvant nivolumab plus concurrent chemoradiation in stage II/III esophageal/gastroesophageal junction cancer.

R. Hales, V. Velculescu, V. Anagnostou, 2019, Journal of Clinical Oncology.

Personalized Risk Prediction in Clinical Oncology Research: Applications and Practical Issues Using Survival Trees and Random Forests

Jon Arni Steingrimsson, Chen Hu, Chen Hu, 2018, Journal of biopharmaceutical statistics.

Deep learning to develop transcriptomic model for survival prediction in TCGA patients with hepatocellular carcinoma.

Chen Hu, F. Kong, A. Chan, 2020 .

Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.

H. Cohen, J. Manola, D. Sargent, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient‐derived tumor organoids predict responses to irinotecan‐based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

H. Clevers, Chen Hu, Guoqiang Hua, 2022, International journal of cancer.

Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer

S. Jolly, Jian-Yue Jin, Chen Hu, 2019, Clinical Cancer Research.

Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer

S. Jolly, K. Lam, Chen Hu, 2021 .

Weighted-Support Vector Machine Learning Classifier of Circulating Cytokine Biomarkers to Predict Radiation-Induced Lung Fibrosis in Non-Small-Cell Lung Cancer Patients

S. Jolly, K. Lam, Jian-Yue Jin, 2021, Frontiers in Oncology.

Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphoma

J. Dai, Chen Hu, K. Men, 2023, BMC Cancer.

Finite Element-Based Personalized Simulation of Duodenal Hydrogel Spacer: Spacer Location Dependent Duodenal Sparing and a Decision Support System for Spacer-Enabled Pancreatic Cancer Radiation Therapy

K. Ding, Junghoon Lee, T. McNutt, 2022, Frontiers in Oncology.

Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy.

T. Pawlik, R. Hruban, E. Jaffee, 2016, International journal of radiation oncology, biology, physics.

Are restricted mean survival time methods especially useful for noninferiority trials?

B. Freidlin, E. Korn, Chen Hu, 2021, Clinical trials.

Preoperative contralateral lung radiation dose is associated with postoperative pulmonary toxicity in patients with locally advanced non-small cell lung cancer treated with trimodality therapy.

R. Hales, S. Broderick, T. McNutt, 2018, Practical radiation oncology.

OA12.03 Initial Reporting of NRG-LU001, Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC

J. Bradley, J. Erasmus, Richard J Lee, 2019, Journal of Thoracic Oncology.

Long-term Outcomes With Planned Multistage Reduced Dose Repeat Stereotactic Radiosurgery for Treatment of Inoperable High-Grade Arteriovenous Malformations: An Observational Retrospective Cohort Study

R. Tamargo, Judy Huang, Chen Hu, 2017, Neurosurgery.

NRG Oncology/RTOG 0937: Randomized Phase 2 Study Comparing Prophylactic Cranial Irradiation (PCI) Alone to PCI and Consolidative Extracranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)

R. Hales, P. Iyengar, J. Bradley, 2016 .

Longitudinal Trends of Financial Toxicity in Patients With Lung Cancer: A Prospective Cohort Study

R. Hales, T. McNutt, Beverly Lee, 2021, JCO oncology practice.

High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy

W. Burns, elliot k fishman, Chen Hu, 2022, Cancer medicine.

W. Curran, R. Jeraj, J. Bradley, 2017, Clinical Lung Cancer.

Randomized phase III trial of concurrent chemoradiation followed by nivolumab or placebo for locally advanced non-small cell lung cancer (NSCLC) (RTOG 3505).

W. Curran, R. Jeraj, J. Bradley, 2017 .

P1.18-12 PACIFIC-4/RTOG 3515: Phase III Study of Durvalumab Following SBRT for Unresected Stage I/II, Lymph-Node Negative NSCLC

J. Bradley, C. Robinson, Chen Hu, 2019, Journal of Thoracic Oncology.

MA 09.08 Receipt of Chest Radiation and Immune-Related Pneumonitis in Patients with NSCLC Treated with Anti-PD-1/PD-L1

R. Hales, D. Ettinger, J. Hayman, 2017 .